Search - tctmd.com

Displaying 81 - 100 of 1006

Sort: Relevancy | Date

Presentation TCT 2023

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

Presenter: Michael Reardon

October 25, 2023

Presentation TCT 2023

TCT 394: Atrial Fibrillation and Chronic Total Occlusion Percutaneous Coronary Intervention Outcomes: Insights From the PROGRESS-CTO Registry

Presenter: Michaella Alexandrou

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

TCT 402: Balloon-Assisted Subintimal Entry (BASE) in Chronic Total Occlusion Percutaneous Coronary Interventions

Presenter: Michaella Alexandrou

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

TCT 1027: Massive pulmonary embolism With Paradoxical Embolism to a Coronary Artery Presenting as InferiorSTEMI, With Concomitant Compression of the Left Main Coronary Artery By Dilated Main Pulmonary Artery

Presentation TCT 2023

TCT 1027: Massive pulmonary embolism With Paradoxical Embolism to a Coronary Artery Presenting as Inferior ST Elevation Myocardial Infarction, With Concomitant Compression of the Left Main Coronary Artery By Dilated Main Pulmonary Artery

Presenter: Michael Fletcher

October 24, 2023

Presentation TCT 2023

Drivers of Value Creation – Have the Priorities Changed?

Presenter: Michael Ennen

October 23, 2023

News Conference News TCT 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Yael L. Maxwell

September 26, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Yael L. Maxwell

September 23, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

News Conference News TCT 2022

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Shelley Wood

September 19, 2022

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Factor XI Inhibition

Presenter: C. Michael Gibson

September 19, 2022

Presentation TCT 2022

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Presenter: Michael Haude

September 19, 2022

Presentation TCT 2022

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Presenter: Michael Reardon

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Predicting the Future of TEER in PMR: New Devices, Expanding Clinical Indications, and Combination Therapies

Presenter: Michael Rinaldi

September 18, 2022

Presentation TCT 2022

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Presenter: C. Michael Gibson

September 18, 2022

Advertisement

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

TCT 394: Atrial Fibrillation and Chronic Total Occlusion Percutaneous Coronary Intervention Outcomes: Insights From the PROGRESS-CTO Registry

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

TCT 402: Balloon-Assisted Subintimal Entry (BASE) in Chronic Total Occlusion Percutaneous Coronary Interventions

Four-Year Outcomes From the EVOLUT Low Risk Trial

TCT 1027: Massive pulmonary embolism With Paradoxical Embolism to a Coronary Artery Presenting as Inferior ST Elevation Myocardial Infarction, With Concomitant Compression of the Left Main Coronary Artery By Dilated Main Pulmonary Artery

Drivers of Value Creation – Have the Priorities Changed?

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Valve Fracture for ViV TAVI Linked With Higher Mortality

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

New and Emerging Pharmacology for ACS: Factor XI Inhibition

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Predicting the Future of TEER in PMR: New Devices, Expanding Clinical Indications, and Combination Therapies

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content